- Report
- September 2025
Global
From €4278EUR$4,900USD£3,704GBP
- Report
- August 2025
- 199 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- September 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- May 2025
- 175 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- April 2025
- 200 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- February 2025
- 200 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- February 2026
- 401 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 274 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- September 2022
- 280 Pages
Global
From €2292EUR$2,625USD£1,984GBP
€4584EUR$5,250USD£3,969GBP
- Report
- September 2024
- 100 Pages
United States
From €4322EUR$4,950USD£3,742GBP
- Report
- May 2024
- 132 Pages
Global
From €3492EUR$3,999USD£3,023GBP
- Report
- March 2024
- 303 Pages
Global
From €4366EUR$5,000USD£3,780GBP
- Report
- October 2021
- 101 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- August 2025
- 150 Pages
India
From €3362EUR$3,850USD£2,910GBP
€4235EUR$4,850USD£3,666GBP
- Report
- February 2019
United States
From €3925EUR$4,495USD£3,398GBP
- Report
- January 2026
- 45 Pages
Global
From €258EUR$295USD£223GBP
- Book
- May 2023
North America
- Book
- November 2022
North America
- Book
- February 2021
North America

The Digestive Disease market is a subset of Gastroenterology, which focuses on the diagnosis and treatment of diseases related to the digestive system. This includes conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Treatment options for these conditions range from lifestyle changes and medications to more invasive procedures such as endoscopy and surgery. The market also includes products and services related to the diagnosis and treatment of digestive diseases, such as diagnostic tests, medical devices, and pharmaceuticals.
Companies in the Digestive Disease market include AbbVie, Allergan, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more